Vitamin E supplements and risk of prostate cancer in U.S. men

Cancer Epidemiology Biomarkers and Prevention

Volumn 13, Issue 3, 2004, Pages 378-382

  Rodriguez, Carmen ^a   Jacobs, Eric J ^a   Mondul, Alison M ^a   Calle, Eugenia E ^a   McCullough, Marjorie L ^a   Thun, Michael J ^a  

^a AMERICAN CANCER SOCIETY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; COHORT ANALYSIS; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG UTILIZATION; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; QUESTIONNAIRE; SMOKING; STATISTICAL ANALYSIS; UNITED STATES; VITAMIN SUPPLEMENTATION; DIET SUPPLEMENTATION; INCIDENCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSTATE TUMOR; RISK FACTOR;

AGED; AGED, 80 AND OVER; ANTIOXIDANTS; COHORT STUDIES; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSTATIC NEOPLASMS; RISK FACTORS; SMOKING; UNITED STATES; VITAMIN E;

EID: 2442673142     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Heinonen O, Albanes D, Virtamo J, et al. Prostate cancer and supplementation with a-tocopherol and β-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst, 1998;90:440-6.
2. Taylor P, Albanes D. Selenium, vitamin E, and prostate cancer-ready for prime time? [editorial]. J Natl Cancer Inst, 1998;90:1184-5.
3. Singh D, Lippman S. Cancer chemoprevention. Part 1: Retinoids and carotenoids and other classic antioxidants. Oncology, 1998;12:1643-8.
4. Institute of Medicine. Dietary references intakes for vitamin C, vitamin E, selenium and carotenoids. Washington, DC: National Academy Press; 2000.
5. Gann P, Giovannucci E, Willet W, Sacks F, Hennekens H, Stampfer M. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res, 1999;59:1225-30.
6. Goodman G, Schaffer S, Omenn G, Chen C, King I. The association between lung cancer and prostate cancer risk, and serum micronutrients: results and lessons learned from β-carotene and retinol efficacy trial. Cancer Epidemiol Biomarkers & Prev, 2003;12:518-26.
7. Helzlsouer K, Huang H-Y, Alberg A, et al. Association between α-tocopherol, selenium, and subsequent prostate cancer. J Natl Cancer Inst, 2000;92:2018-23.
8. Huang H-Y, Alberg A, Norkus E, Hoffman S, Comstock G, Helzlsouer K. Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer. Am J Epidemiol, 2003;157:335-44.
9. Chopra R, Bhagavan H. Relative bioavailabilities of natural and synthetic vitamin E formulations containing mixed tocopherols in human subjects. Int J Vit Nutr Res, 1999;69:92-5.
10. Giovannucci E. γ-Tocopherol: a new player in prostate cancer prevention? J Natl Cancer Inst, 2000;92:1966-7.
11. Chan J, Stampfer M, Ma J, Rimm E, Willet W, Giovannucci E. Supplemental vitamin E intake and prostate cancer risk in a large cohort of men in the United States. Cancer Epidemiol Biomarkers & Prev, 1999;8:893-9.
12. Calle E. The American Cancer Society Nutrition Survey - rationale, study design, and baseline characteristics. Cancer, 2002;94:2490-501.
13. Calle EE, Terrell DD. Utility of the National Death Index for ascertainment of mortality among cancer prevention study II participants. Am J Epidemiol, 1993;137:235-41.
14. Block G, Haran A, Naughton D. A reduced dietary questionnaire: development and validation. Epidemiology, 1990;1:58-64.
15. Block G, Coyl L, Smucker R, Harlan L. Health habits and history questionnaire: diet history and other risk factors. Personal computer system documentation. Bethesda, MD: National Cancer Institute Division of Cancer Prevention and Control. National Institute of Health; 1989.
16. Kleinbaum D. Survival analysis: a self-learning text. New York, NY: Springer-Verlag; 1996.
17. Hosmer D, Lemeshow S. Applied logistic regression. John Wiley and Sons;1989.
18. Schulman CC, Ekane S, Zlotta A. Nutrition and prostate cancer: evidence or suspicion? Urology, 2001;58:318-34.
19. Vlajinac H, Marinkovic J, Ilic M, Kocev N. Diet and prostate cancer: a case-control study. Eur J Cancer, 1997;33:101-7.
20. Krystal AR, Stanford JL, Cohen JH, Wicklund K, Patterson RE. Vitamin and mineral supplement use is associated with reduced risk of prostate cancer. Cancer Epidemiol Biomarkers Prev, 1999;8:887-92.
21. Eichholzer M, Stahelin H, Gey K, Ludin E, Bernasconi F. Prediction of male cancer mortality by plasma levels of interacting vitamins: 17-year follow-up of the prospective Basel study. Int J Cancer, 1996;66:145-50.
22. Nomura A, Stemmermann G, Lee J, Craft N. Serum micronutrients and prostate cancer in Japanese Americans in Hawaii. Cancer Epidemiol Biomarkers & Prev, 1997;6:487-91.
23. Hartman T, Albanes D, Pietinen P, et al. The association between baseline vitamin E, selenium, and prostate cancer in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Cancer Epidemiol Biomarkers & Prev, 1998;7:335-40.
24. Hsing A, Comstock G, Abbey H, Polk B. Serologic precursors of cancer, retinol, carotenoids, and tocopherol and risk of prostate cancer. J Natl Cancer Inst, 1990;82:941-6.
25. Knekt P, Aromaa A, Maatela J, et al. Serum vitamin E and risk of cancer among Finnish men during a 10-year follow-up. Am J Epidemiol, 1998;127:28-41.